Fadhil HR, Al-Jumaili AA, Al-Ani NA. Cost-effectiveness Analysis of Reference Infliximab (Remicade) Compared to its Biosimilar (Remsima) in Iraqi Patients with Rheumatoid Arthritis (Conference Paper )#. Iraqi Journal of Pharmaceutical Sciences [Internet]. 2023 Feb. 16 [cited 2024 Nov. 5];31(Suppl.):100-1. Available from: https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/2033